Evidence map›Paper›PMID 31413749›Full record

ArticleJournal of Cancer2019

BolA family member 2 enhances cell proliferation and predicts a poor prognosis in hepatocellular carcinoma with tumor hemorrhage.

Jia Luo, Dong Wang, Sai Zhang, Kuan Hu, Haijun Wu, Juanni Li, Zhiming Wang, Yiming Tao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Observational
  2. Article
  3. Review
  4. Integrative analysis of the role ofFrontiers in genetics · 2023
    Article
  5. Article
  6. Article
  7. PBX1: a key character of the hallmarks of cancer.Journal of molecular medicine (Berlin, Germany) · 2021
    Review
  8. Article
  9. Identification of an Immune Score-Based Gene Panel with Prognostic Power for Oral Squamous Cell Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jia LuoDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, China.
Dong WangDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, China.
Sai ZhangInstitute of Medical Sciences, Xiangya Hospital, Central South University, Changsha 410008, China.
Kuan HuDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, China.
Haijun WuDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China.
Juanni LiDepartment of Pathology, Xiangya Hospital, Central South University, Changsha 410008, China.
Zhiming WangDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, China.
Yiming TaoDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, China.
Central South University · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BolA family member 2Hepatocellular carcinomaIron metabolismTumor hemorrhageTumor microenvironment

Identifiers

PMID31413749
PMCPMC6691716
OpenAlexW2963229112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.